| Description | BT44 is a novel, second-generation glial cell line_x0002_derived neurotropic factor mimetic with improved biological activity and is a lead compound for the treatment of neurodegenerative disorders. |
| molecular weight | 577.59 |
| Molecular formula | C28H27F4N3O4S |
| CAS | 924759-42-2 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| Solubility | DMSO: 45 mg/mL (77.91 mM) |
| References | 1. Haider MS, et al. Biological Activity In Vitro, Absorption, BBB Penetration, and Tolerability of Nanoformulation of BT44:RET Agonist with Disease-Modifying Potential for the Treatment of Neurodegeneration. Biomacromolecules. 2022 Oct 11. |